Elppe Chemicals Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 26-06-2024
- Paid Up Capital ₹ 5.40 M
as on 26-06-2024
- Company Age 38 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 52.90 Cr
as on 26-06-2024
- Satisfied Charges ₹ 83.82 Cr
as on 26-06-2024
- Revenue -14.24%
(FY 2023)
- Profit -75.33%
(FY 2023)
- Ebitda -57.94%
(FY 2023)
- Net Worth 6.11%
(FY 2023)
- Total Assets 7.69%
(FY 2023)
About Elppe Chemicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 5.40 M.
The company currently has active open charges totaling ₹52.90 Cr. The company has closed loans amounting to ₹83.82 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sulbha Bardeskar, Pedat Pavalu, and Amol Bardeshkar serve as directors at the Company.
- CIN/LLPIN
U24100MH1986PTC041448
- Company No.
041448
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Oct 1986
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Raigad, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Elppe Chemicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sulbha Bardeskar  | Director | 28-Jan-1999 | Current |
| Pedat Pavalu | Director | 30-Oct-1986 | Current |
| Amol Bardeshkar | Additional Director | 15-Jul-2016 | Current |
Financial Performance of Elppe Chemicals.
Elppe Chemicals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.24% decrease. The company also saw a substantial fall in profitability, with a 75.33% decrease in profit. The company's net worth moved up by a moderate rise of 6.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Elppe Chemicals?
In 2023, Elppe Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 Feb 2020 | ₹20.00 Cr | Open |
Axis Bank Limited Creation Date: 28 Jan 2020 | ₹17.50 Cr | Open |
Others Creation Date: 16 Jun 2016 | ₹14.00 Cr | Open |
How Many Employees Work at Elppe Chemicals?
Elppe Chemicals has a workforce of 119 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Elppe Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elppe Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
